Moreover, the study further analyzed the relationship between CD155 and clinical characteristics, and it was observed that abnormal expression of CD155 was related to tumor stage, LN metastasis, and distant metastasis, which meant that differential expression of CD155 in various cancers might lead to different biological responses in the patients. The gene discussed is PVR; the disease is cancer.